Levonorgestrel/Etinilestradiol Stada

Levonorgestrel and Ethinylestradiol, the active ingredients in Levonorgestrel/Etinylestradiol Stada, are combined oral contraceptives presented as tablets for oral use. They work together to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. Additionally, it alters the endometrium to reduce the chance of implantation.

GNH USA supplies Levonorgestrel/Etinylestradiol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains across multiple regions.

Levonorgestrel/Ethinylestradiol is a combined oral contraceptive used to prevent pregnancy and manage hormone‑related menstrual conditions.

- Contraception: provides reliable hormonal birth control for women of child‑bearing age. - Dysmenorrhea management: reduces painful menstrual cramps when prescribed. - Acne treatment: helps improve androgen‑related skin lesions in eligible patients.

Adverse reactions may occur with any hormonal contraceptive.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Intermenstrual spotting: light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Severe allergic reaction: symptoms such as rash, swelling, or difficulty breathing.

Before initiating therapy, consider the following safety measures.

- Thrombotic risk assessment: evaluate personal or family history of clotting disorders. - Smoking status review: avoid use in women over 35 who smoke. - Liver function evaluation: contraindicated in severe hepatic disease. - Blood pressure monitoring: control hypertension prior to use. - Missed dose guidance: follow label instructions for missed tablets. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture.

Levonorgestrel/Ethinylestradiol may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin). - Rifampin and other strong CYP3A4 inducers. - St. John's wort herbal supplement.

Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole. - Selective serotonin reuptake inhibitors (SSRIs).